Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

During the last two decades, treatment options for patients with multiple sclerosis (MS) have broadened tremendously. All agents that are currently approved for clinical use have potential side effects, and a careful risk–benefit evaluation is part of a decision algorithm to identify the optimal tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Rommer, P S, Zettl, U K, Kieseier, B, Hartung, H-P, Menge, T, Frohman, E, Greenberg, B M, Hemmer, B, Stüve, O
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2014
Subjects:
Review Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927900/
https://ncbi.nlm.nih.gov/pubmed/24102425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12206
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items